ARTICLE | Clinical News
FS-069 ultrasound contrast agent for echocardiography: Phase III trial
April 8, 1996 7:00 AM UTC
Molecular Biosystems Inc. (MB), San Diego, Calif. Product: FS-069 ultrasound contrast agent for echocardiography Use: Diagnose cardiac function Status: MB completed enrollment of its 200-patient Phase...